buy generic avodart au

FILE PHOTO: A vial and sryinge are seen in front of a displayed Johnson&Johnson logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration

(Reuters) – Europe’s drug regulator said on Wednesday it expects to issue a recommendation on Johnson & Johnson’s COVID-19 vaccine next week and that it continues to believe that the benefits of the shot outweighed the risks of side effects.

The European Medicines Agency said J&J was in contact with national authorities, recommending to store the doses already received until the safety committee issues an expedited recommendation.

Source: Read Full Article